Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries

Fig. 1

Pharmachild graphical depiction over time of the key efficacy and safety data. Drug exposure and adverse events are represented in parallel to Juvenile Arthritis Disease Activity Score (JADAS) pattern. The Excel spreadsheet with all the data could be downloaded automatically by all participating centers. In the figure, an example of a patient from an Italian center is presented

Back to article page